MarketPeel
Chief R&D Officer
Mon, Mar 14, 2022
Mar 14
sold $3.40k of FATE
100 shares @ $34.04
Decreased holdings by -0.10%
Net across this filing: 0.00% (+0 shares)
64th largest trade (out of 82)
Option ExercisePositive 90D History
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +0.0% (+0 shares)
86% win rate · +22.1% median edge vs SPY (7 trades, 90-day · small sample)
Price 52% below 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
FATEFATE THERAPEUTICS INC
HealthcareBiotechnology
1D0.00%
1W-4.67%
1M+1.66%
3M
6M
1Y

Recent insider activity at FATE

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback